OrbusNeich Medical Group Holdings Limited (6929.HK)

HKD 3.5

(-0.85%)

EBITDA Summary of OrbusNeich Medical Group Holdings Limited

  • OrbusNeich Medical Group Holdings Limited's latest annual EBITDA in 2023 was 53.96 Million USD , up 81.55% from previous year.
  • OrbusNeich Medical Group Holdings Limited's latest quarterly EBITDA in 2024 Q2 was 9.17 Million USD , down 0.0% from previous quarter.
  • OrbusNeich Medical Group Holdings Limited reported an annual EBITDA of 27.13 Million USD in 2022, up 250.98% from previous year.
  • OrbusNeich Medical Group Holdings Limited reported an annual EBITDA of 8.3 Million USD in 2021, down -29.91% from previous year.
  • OrbusNeich Medical Group Holdings Limited reported a quarterly EBITDA of 9.17 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • OrbusNeich Medical Group Holdings Limited reported a quarterly EBITDA of 8.08 Million USD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of OrbusNeich Medical Group Holdings Limited (2023 - 2019)

Historical Annual EBITDA of OrbusNeich Medical Group Holdings Limited (2023 - 2019)

Year EBITDA EBITDA Growth
2023 53.96 Million USD 81.55%
2022 27.13 Million USD 250.98%
2021 8.3 Million USD -29.91%
2020 12.74 Million USD 18.4%
2019 10.03 Million USD 0.0%

Peer EBITDA Comparison of OrbusNeich Medical Group Holdings Limited

Name EBITDA EBITDA Difference
Kaisa Health Group Holdings Limited 27.56 Million HKD -95.809%
Elegance Optical International Holdings Limited -51.64 Million HKD 204.494%
Arts Optical International Holdings Limited 77.08 Million HKD 29.992%
Kelfred Holdings Limited 14.24 Million HKD -278.875%
Modern Dental Group Limited 696.64 Million HKD 92.253%